This is the list of the largest public listed companies in the Biotechnology industry from the United States by market capitalization with links to their reference stock.
Company Profile:
Chiasma, Inc.
Market Cap (USD):
$253.0 M
(July 1, 2021)
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Progenity, Inc.
Market Cap (USD):
$248.7 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Epizyme, Inc.
Market Cap (USD):
$247.5 M
(Aug. 1, 2022)
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Vanda Pharmaceuticals Inc.
Market Cap (USD):
$241.1 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Rigel Pharmaceuticals, Inc.
Market Cap (USD):
$240.6 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
XOMA Corporation
Market Cap (USD):
$240.2 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Foghorn Therapeutics Inc.
Market Cap (USD):
$238.1 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Stoke Therapeutics, Inc.
Market Cap (USD):
$234.9 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
INmune Bio, Inc.
Market Cap (USD):
$232.5 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Checkmate Pharmaceuticals, Inc.
Market Cap (USD):
$231.4 M
(May 1, 2022)
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
scPharmaceuticals Inc.
Market Cap (USD):
$227.7 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Puma Biotechnology, Inc.
Market Cap (USD):
$223.1 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Praxis Precision Medicines, Inc.
Market Cap (USD):
$215.9 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Ovid Therapeutics Inc.
Market Cap (USD):
$215.6 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Verastem, Inc.
Market Cap (USD):
$214.3 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Sutro Biopharma, Inc.
Market Cap (USD):
$212.7 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Lineage Cell Therapeutics, Inc.
Market Cap (USD):
$210.0 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Compass Therapeutics, Inc.
Market Cap (USD):
$207.8 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Prelude Therapeutics Incorporated
Market Cap (USD):
$207.3 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Larimar Therapeutics, Inc.
Market Cap (USD):
$205.5 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
KemPharm, Inc.
Market Cap (USD):
$205.3 M
(Jan. 1, 2023)
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Silverback Therapeutics, Inc.
Market Cap (USD):
$204.5 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Inovio Pharmaceuticals, Inc.
Market Cap (USD):
$196.5 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Codexis, Inc.
Market Cap (USD):
$194.8 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Werewolf Therapeutics, Inc.
Market Cap (USD):
$194.0 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Spectrum Pharmaceuticals, Inc.
Market Cap (USD):
$192.9 M
(July 1, 2023)
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Omeros Corporation
Market Cap (USD):
$192.4 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Gossamer Bio, Inc.
Market Cap (USD):
$191.6 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Aldeyra Therapeutics, Inc.
Market Cap (USD):
$190.0 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Merrimack Pharmaceuticals, Inc.
Market Cap (USD):
$189.8 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology